July 25th 2024
Multiple confirmed responses in a phase 2 trial support the FDA designation for the experimental therapy in squamous cell carcinoma of the head and neck.
Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Dialogues With the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: Looking at EGFR, ALK, IO, and Beyond…
View More
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Lobectomy More Effective, Economical for Suspected Papillary Thyroid Cancer
October 25th 2016Undergoing a lobectomy for thyroid nodules suspicious for papillary thyroid cancer on fine-needle aspiration was more cost effective and was associated with greater effectiveness compared with total thyroidectomy.
Metformin Delays Progression of Thyroid Tumor Metastases in Mice
September 26th 2016Mitochondrial glycerophosphate dehydrogenase (mGPDH) is overexpressed in differentiated thyroid cancer (DTC) tissue, and metformin, which downregulates mGPDH, is associated with slowed growth in metastatic DTC tumors in mice.
Long-Term Data Validate Low-Dose I-131 for Low-Risk Thyroid Cancer
September 25th 2016Five years after treatment, low-dose postsurgical radioiodine (I-131) ablation for low-risk thyroid cancer offers outcomes equivalent to those seen following higher-dose ablation, according to a long-term follow-up analysis by French researchers.
Study Calls for Reclassification of Thyroid Tumors as Non-Cancerous
April 22nd 2016A new study is calling for a change in name for certain thyroid tumors. Patients diagnosed with what is currently known as noninvasive encapsulated follicular variant of papillary thyroid carcinoma have a very low risk for recurrence and therefore, researchers have suggested renaming the condition.
Pre-Op Ultrasound ID’s Important Prognostic Characteristics in Thyroid Cancer
March 18th 2016Researchers have identified several characteristics of metastatic papillary thyroid cancer shown on preoperative ultrasound-such as node matting-that are associated with extranodal extension, an important prognostic factor linked with this disease.